Found "Health Promotion": 1,056 results
Sort by
Relevance

[Webinar] How primary healthcare services coped with the COVID-19 pandemic and what is the future direction?

The COVID-19 pandemic has taken a toll on the lives and livelihoods of people since 2020 and it has disrupted provision of health services, including for primary health care which is the first point of contact for patients and the first line of defense for the health system.Learn how primary healthc

[Webinar] Use of Health Service Research for Clinical Practice

Health service research (HSR) has changed the way healthcare is delivered to patients and its and quality. The research has continually generated results that, if translated into policy and clinical practices, can improve health outcomes, and provide better patient care and treatment. However, the t

Horizontal scanning for high-potential, high-demand and high-technological capability medical innovations in Thailand

The Thai Innovation List was established in 2015 to compile products and services developed through Thailand’s scientific and technological knowledge and research capacity. The initiative was designed to support and promote the utilization of Thai innovations for economic development and commercialization. Medical innovations account for approxim

Survey Results: What Do Thai People Think About Health Equity?

The issue of health equity is important to Thai people, but there has not been a clear measure of its significance. Findings from the “Health Inequality Aversion Survey” confirm that Thai people highly value health equity, although differences exist between the general public and policymakers

Methods for Evaluation of Surrogate Endpoints for HTA Decision Making

Abstract Surrogate endpoints are frequently used as primary outcomes in clinical trials. This is appropriate when they are validated for their ability to predict clinical benefit measured on patient-relevant target outcome(s). Such validation is often lacking, thus increasing uncertainty in the dec

Indoor Air Pollution of Volatile Organic Compounds (VOCs) in Hospitals in Thailand: Review of Current Practices, Challenges, and Recommendations

Indoor air pollution has become a significant concern, contributing to the decline in air quality through the presence of gaseous pollutants and particulate matter, especially under poor ventilation. Hospitals, functioning as non-industrial microenvironments, particularly in Thailand, face challenge

Indoor Air Pollution of Volatile Organic Compounds (VOCs) in Hospitals in Thailand: Review of Current Practices, Challenges, and Recommendations

Indoor air pollution has become a significant concern, contributing to the decline in air quality through the presence of gaseous pollutants and particulate matter, especially under poor ventilation. Hospitals, functioning as non-industrial microenvironments, particularly in Thailand, face challenges due to insufficient and incomplete databases for

Development of reference case for economic evaluation on clinical artificial intelligence for health insurance reimbursement in Thailand

The development of artificial intelligence (AI) in healthcare is advancing rapidly and playing an important role in healthcare worldwide. However, real-world implementation remains challenging in terms of economic value, patient data security, and acceptance by health professionals. Hence, this study was conducted with three main components: (1) a

Gao Qi

Gao Qi is a research assistant at Saw Swee Hock School of Public Health, National University of Singapore in collaboration with MIDAS. Research fields include framework construction of health innovation process, early health technology assessment, and traditional health technology assessment. Interested in health policy effects and health innovatio

Rapid Health Technology Assessment: A Cost-Utility and Budget Impact Analysis of Abiraterone Acetate for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) After Docetaxel Therapy

Management of advanced prostate cancer, particularly in cases of metastatic castration-resistant prostate cancer (mCRPC), typically involves first-line treatment with the chemotherapeutic agent docetaxel. Nevertheless, disease progression following docetaxel therapy remains a major challenge, as there are currently no therapeutic options listed in
10 / Page